This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (39) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Frederickson, C. J. Articles by Cuajungco, M. P. Search for Related Content PubMed PubMed Citation Articles by Frederickson, C. J. Articles by Cuajungco, M. P. Social Bookmarking                   What's this?

Zinc and Excitotoxic Brain Injury: A New Model

NeuroBioTex, Inc., 101 Christopher Columbus Blvd., Galveston, TX 77550chris{at}neurobiotex.com

Wolfgang Maret

Math P. Cuajungco

It has been nearly 15 years since the suggestion that synaptically released Zn2+ might contribute to excitotoxic brain injury after seizures, stroke, and brain trauma. In the original "zinc-translocation" model, it was proposed that synaptically released Zn2+ ions penetrated postsynaptic neurons, causing injury. According to the model, chelating zinc in the cleft was predicted to be neuroprotective. This proved to be true: zinc chelators have proved to be remarkably potent at reducing excitotoxic neuronal injury in many paradigms. Promising new zinc-based therapies for stroke, head trauma, and epileptic brain injury are under development. However, new evidence suggests that the original translocation model was incomplete. As many as three sources of toxic zinc ions may contribute to excitotoxicity: presynaptic vesicles, postsynaptic zincsequestering proteins, and (more speculatively) mitochondrial pools. The authors present a new model of zinc currents and zinc toxicity that offers expanded opportunities for zinc-selective therapeutic chelation interventions.

Key Words: Nitric oxide • Oxidative stress • Cerebral ischemia • Metal chelator • Zinc

The Neuroscientist, Vol. 10, No. 1, 18-25 (2004)
DOI: 10.1177/1073858403255840


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. K. Heyland, N. Jones, N. Z. Cvijanovich, and H. Wong Zinc Supplementation in Critically Ill Patients: A Key Pharmaconutrient? JPEN J Parenter Enteral Nutr, September 1, 2008; 32(5): 509 - 519. [Abstract] [Full Text] [PDF]

				J. J. Bruinsma, D. L. Schneider, D. E. Davis, and K. Kornfeld Identification of Mutations in Caenorhabditis elegans That Cause Resistance to High Levels of Dietary Zinc and Analysis Using a Genomewide Map of Single Nucleotide Polymorphisms Scored by Pyrosequencing Genetics, June 1, 2008; 179(2): 811 - 828. [Abstract] [Full Text] [PDF]

				E. Park PhD, J. D. Bell BSc, and A. J. Baker MD Traumatic brain injury: Can the consequences be stopped? Can. Med. Assoc. J., April 22, 2008; 178(9): 1163 - 1170. [Abstract] [Full Text] [PDF]

				I. G. Gazaryan, I. P. Krasinskaya, B. S. Kristal, and A. M. Brown Zinc Irreversibly Damages Major Enzymes of Energy Production and Antioxidant Defense Prior to Mitochondrial Permeability Transition J. Biol. Chem., August 17, 2007; 282(33): 24373 - 24380. [Abstract] [Full Text] [PDF]

				L. Tretter and V. Adam-Vizi Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress Phil Trans R Soc B, December 29, 2005; 360(1464): 2335 - 2345. [Abstract] [Full Text] [PDF]